Sign up to save your podcasts
Or
Share Amicus Therapeutics CEO John Crowley
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amicus Therapeutics CEO John Crowley
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.3
8080 ratings
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Goldman Sachs Talks
View all
Notes on the Week Ahead
193 Listeners
Insights Now
92 Listeners
Masters in Business
2,188 Listeners
Goldman Sachs Exchanges
983 Listeners
Capital Allocators – Inside the Institutional Investment Industry
800 Listeners
Eye On The Market
289 Listeners
UBS On-Air: Market Moves
178 Listeners
Making Sense
58 Listeners
Thoughts on the Market
1,267 Listeners
At Any Rate
77 Listeners
The Memo by Howard Marks
407 Listeners
Global Data Pod
22 Listeners
The View From Apollo
25 Listeners
Goldman Sachs The Markets
72 Listeners
Bloomberg Talks
14 Listeners